News
Cardinal Health, Inc. (NYSE:CAH) has surged by nearly 39% since the start of 2025. The company remains focused on ...
3d
Zacks Investment Research on MSNCardinal Health (CAH) Laps the Stock Market: Here's WhyCardinal Health (CAH) closed the most recent trading day at $165.61, moving +1.14% from the previous trading session. This move outpaced the S&P 500's daily gain of 0.8%. Meanwhile, the Dow ...
Shares of Cardinal Health Inc. CAH advanced 1.14% to $165.61 Thursday, on what proved to be an all-around positive trading ...
Cardinal Health, Inc. (NYSE:CAH) is an American healthcare company. Cramer has started discussing the stock quite frequently ...
Congenital adrenal hyperplasia (CAH) is a rare autosomal recessive disease1 with an estimated global incidence of approximately 1 in 14,000–18,000 live births2A phase II trial has recently been ...
9d
Zacks Investment Research on MSNCardinal Health (CAH) Dips More Than Broader Market: What You Should KnowIn the latest close session, Cardinal Health (CAH) was down 1.21% at $163.40. This change lagged the S&P 500's daily loss of 0.22%. At the same time, the Dow added 0.08%, and the tech-heavy Nasdaq ...
It’s Friday which means it’s time for our Pet of the Week! SICSA joined featuring Soh Cah Toa! For more information, click ...
Glenn Medical Center, a 25-bed hospital in Willows, Calif., is on the verge of losing its “critical access hospital” designation due to a geographic classification dispute with CMS. Hospital leaders ...
Today, Benzinga 's options scanner spotted 9 uncommon options trades for Cardinal Health. This isn't normal. The overall sentiment of these big-money traders is split between 55% bullish and 44%, ...
I prefer high-yielding dividend stocks that enable me to redeploy cash at regular intervals. Check out two stocks poised to deliver potentially strong returns.
Nearly a dozen hospitals across the Buckeye State have been labeled “at risk,” according to data obtained and released by a U.S. senator’s office.
Crinetics Pharmaceuticals trades at a steep discount while maintaining strong analyst support and a ~$3B valuation. Learn why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results